Agios Pharm (AGIO) Insider Trading
- $153,404,205.75
- $155,562,864.87
- Sept. 26, 2024
- Scott Biller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 9, 2015 | SVP | 15,000 | $105.81 | Sell | $1,587,150.00 | |
Feb. 2, 2015 | CEO | 10,400 | $114.31 | Sell | $1,188,824.00 | |
Jan. 2, 2015 | Insider | 4,500 | $110.08 | Sell | $495,360.00 | |
Jan. 2, 2015 | COO | 12,000 | $110.08 | Sell | $1,320,960.00 | |
Jan. 2, 2015 | CEO | 13,000 | $110.08 | Sell | $1,431,040.00 | |
Dec. 16, 2014 | Major Shareholder | 228,645 | $110.75 | Buy | $25,322,433.75 | |
Dec. 16, 2014 | Director | 1,806 | $110.75 | Buy | $200,014.50 | |
Dec. 1, 2014 | CEO | 13,000 | $97.03 | Sell | $1,261,390.00 | |
Dec. 1, 2014 | Insider | 4,500 | $97.03 | Sell | $436,635.00 | |
Dec. 1, 2014 | COO | 12,000 | $97.03 | Sell | $1,164,360.00 | |
Nov. 3, 2014 | Insider | 4,500 | $81.71 | Sell | $367,695.00 | |
Nov. 3, 2014 | SVP | 2,000 | $81.71 | Sell | $163,420.00 | |
Nov. 3, 2014 | COO | 13,000 | $81.71 | Sell | $1,062,230.00 | |
Oct. 1, 2014 | COO | 13,000 | $60.07 | Sell | $780,910.00 | |
Oct. 1, 2014 | SVP | 1,500 | $60.07 | Sell | $90,105.00 | |
Oct. 1, 2014 | Insider | 4,500 | $60.07 | Sell | $270,315.00 | |
Sept. 26, 2014 | CEO | 60,000 | $62.68 | Sell | $3,760,800.00 | |
Sept. 26, 2014 | SVP | 17,500 | $56.53 | Sell | $989,275.00 | |
Sept. 19, 2014 | Insider | 37,996 | $50.45 | Sell | $1,916,898.20 | |
Sept. 2, 2014 | SVP | 10,000 | $46.30 | Sell | $463,000.00 | |
Sept. 2, 2014 | COO | 13,000 | $46.30 | Sell | $601,900.00 | |
Sept. 2, 2014 | Insider | 4,500 | $46.30 | Sell | $208,350.00 | |
Aug. 26, 2014 | COO | 5,000 | $45.05 | Sell | $225,250.00 | |
Aug. 11, 2014 | CEO | 4,530 | $40.17 | Sell | $181,970.10 | |
July 1, 2014 | CEO | 13,000 | $46.52 | Sell | $604,760.00 | |
July 1, 2014 | SVP | 3,500 | $46.52 | Sell | $162,820.00 | |
July 1, 2014 | COO | 12,000 | $46.52 | Sell | $558,240.00 | |
July 1, 2014 | Insider | 4,500 | $46.52 | Sell | $209,340.00 | |
June 23, 2014 | Director | 2,300 | $43.98 | Buy | $101,154.00 | |
June 20, 2014 | Insider | 2,004 | $50.05 | Sell | $100,300.20 | |
June 13, 2014 | COO | 5,000 | $45.27 | Sell | $226,350.00 | |
June 3, 2014 | COO | 7,000 | $34.47 | Sell | $241,290.00 | |
May 6, 2014 | COO | 5,000 | $45.73 | Sell | $228,650.00 | |
May 1, 2014 | SVP | 2,000 | $42.39 | Sell | $84,780.00 | |
May 1, 2014 | Insider | 4,500 | $42.39 | Sell | $190,755.00 | |
May 1, 2014 | COO | 7,000 | $42.39 | Sell | $296,730.00 | |
April 29, 2014 | Director | 2,250 | $44.00 | Buy | $99,000.00 | |
April 29, 2014 | major shareholder | 294,800 | $44.00 | Buy | $12,971,200.00 | |
April 7, 2014 | SVP | 2,000 | $45.17 | Sell | $90,340.00 | |
April 7, 2014 | COO | 3,000 | $45.17 | Sell | $135,510.00 | |
April 1, 2014 | COO | 12,000 | $38.08 | Sell | $456,960.00 | |
April 1, 2014 | SVP | 4,000 | $38.08 | Sell | $152,320.00 | |
April 1, 2014 | Insider | 4,500 | $38.08 | Sell | $171,360.00 | |
March 7, 2014 | SVP | 17,468 | $42.11 | Sell | $735,577.48 | |
March 7, 2014 | COO | 14,646 | $41.41 | Sell | $606,490.86 | |
March 3, 2014 | COO | 8,000 | $29.85 | Sell | $238,800.00 | |
March 3, 2014 | Insider | 6,000 | $29.85 | Sell | $179,100.00 | |
Feb. 10, 2014 | SVP | 6,000 | $30.44 | Sell | $182,640.00 | |
Jan. 27, 2014 | SVP | 7,000 | $26.29 | Sell | $184,030.00 | |
Jan. 21, 2014 | SVP | 10,000 | $34.71 | Sell | $347,100.00 |
Insiders are both buying and selling Agios Pharm stock.
The insider traders at Agios Pharm are: Scott Biller, David P Schenkein, Lewis Clayton Jr. Cantley, John Duncan Higgons, Glenn Goddard, Christopher Bowden, Steven L Hoerter, Theodore James Jr. Washburn, Carman Alenson, Brian Goff, Jacqualyn A Fouse, James William Burns, John Maraganore, Cecilia Jones, Kaye I Foster-Cheek, Celgene European Investment Co, Robert Nelsen, Darrin Miles, Corp /De/ Celgene, Tsveta Milanova, Sarah Gheuens, and David Scadden
The most active insider trader at Agios Pharm is Scott Biller with 46 trades.
David P Schenkein has sold the most Agios Pharm stock with a total value of $52,693,359.25.
Celgene European Investment Co has bought the most Agios Pharm stock with a total value of $112,876,552.75.
The most recent insider trade for Agios Pharm was on Sept. 26, 2024.
The single biggest insider buy for Agios Pharm was from Corp /De/ Celgene with a total value of $57,027,318.00 on Jan. 23, 2018.
The single biggest insider sell for Agios Pharm was from Robert Nelsen with a total value of $11,998,527.52 on Feb. 28, 2017.